N-(2-cyanomethylsulfonyl-5-fluorophenyl)acetamide | 293316-40-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-cyanomethylsulfonyl-5-fluorophenyl)acetamide
• 英文别名: N-(2-cyanomethylsulfonyl-5-fluoro-phenyl)acetamide；N-[2-(cyanomethylsulfonyl)-5-fluorophenyl]acetamide
• CAS: 293316-40-2
• 化学式: C₁₀H₉FN₂O₃S
• 分子量: 256.257
• InChiKey: ODHZNQGAMVPNAV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  95.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-(2-cyanomethylsulfonyl-5-fluorophenyl)acetamide 在 sodium hydroxide 作用下， 生成 6-Fluoro-3-methyl-4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide
  参考文献：
  名称：

  Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use

  摘要：

  本发明涉及融合的1,4-噻嗪-2-碳腈衍生物，其组合物以及制备这些化合物的方法。这些化合物在治疗中枢神经系统、心血管系统、呼吸系统、消化系统和内分泌系统疾病方面具有用途。

  公开号：

  US06232310B1
• 作为产物：
  描述：

  2-氨基-5-氟苯并噻唑 在 吡啶 、 氢氧化钾 、 双氧水 、 溶剂黄146 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 9.33h， 生成 N-(2-cyanomethylsulfonyl-5-fluorophenyl)acetamide
  参考文献：
  名称：

  Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels

  摘要：

  1, 2,4-Thiadiazine derivatives, like 3-methyl-7-chlorobenzo-4H-1,2,4-thiadiazine 1,1-dioxide, diazoxide and 7-chloro-3-isopropylamino-4H-benzo-1,2,4-thiadiazine 1,1-dioxide, BPDZ 73, are potent openers of Kir6.2/SUR1 K-ATP channels. To explore the structure-activity relationship of this series of K-ATP openers, 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyano-methylsulfonylphenyl)acylamide derivatives were synthesized from 2-acetylamino-5-chloro-benzenesulfonic acid pyridinium salt or 2-aminobenzenethiols. The 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide derivatives (e.g., 7-chloro-3-isopropylamino-4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide, 3f) were found to activate K-ATP channels as indicated by their ability to hyperpolarize beta cell membrane potential, to inhibit glucose-stimulated insulin release in vitro and to increase ion currents through Kir6.2/SUR1 channel as measured by patch clamp. The potency and efficacy of, for example, 3f is however significantly reduced compared to the corresponding 4H-1,2,4-benzothiadiazine 1,1-dioxide derivatives. Opening of the 4H-1,2,4-thiadiazine ring to get (e.g., 2-cyanomethylsulfonyl-4-fluorophenyl) carbamic acid isopropyl ester (4c) gives rise to compounds, which are able to open K-ATP channels but with considerable reduced potency compared to, for example, diazoxide. Compound 3a, 7-chloro-3-methyl-4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide, which inhibits insulin release in vitro from beta cells and rat islets, reduces plasma insulin levels and blood pressure in anaesthetized rats upon intravenous administration. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2004.09.051

文献信息

• Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
  申请人：Novo Nordisk A/S

  公开号：US06232310B1

  公开（公告）日：2001-05-15

  The present invention relates to fused 1,4-thiazine-2-carbonitrile derivatives, compositions thereof and methods for preparing the compounds. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.

  本发明涉及融合的1,4-噻嗪-2-碳腈衍生物，其组合物以及制备这些化合物的方法。这些化合物在治疗中枢神经系统、心血管系统、呼吸系统、消化系统和内分泌系统疾病方面具有用途。
• FUSED 1,4-THIAZINE-2-CARBONITRILE DERIVATIVES, THEIR PREPARATION AND USE
  申请人：NOVO NORDISK A/S

  公开号：EP1163233A1

  公开（公告）日：2001-12-19
• US6232310B1
  申请人：——

  公开号：US6232310B1

  公开（公告）日：2001-05-15
• [EN] FUSED 1,4-THIAZINE-2-CARBONITRILE DERIVATIVES, THEIR PREPARATION AND USE<br/>[FR] DERIVES DE 1,4-THIAZINE-2-CARBONITRILE FUSIONNES, LEUR PREPARATION ET LEUR UTILISATION
  申请人：NOVO NORDISK AS

  公开号：WO2000055147A1

  公开（公告）日：2000-09-21

  The present invention relates to fused 1,4-thiazine-2-carbonitrile derivatives, compositions thereof and methods for preparing the compounds. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
• Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels
  作者：Søren C. Schou、Holger C. Hansen、Tina M. Tagmose、Harrie C.M. Boonen、Anne Worsaae、Michael Drabowski、Philip Wahl、Per O.G. Arkhammar、Thora Bodvarsdottir、Marie-Hélène Antoine、Philippe Lebrun、John Bondo Hansen

  DOI：10.1016/j.bmc.2004.09.051

  日期：2005.1

  1, 2,4-Thiadiazine derivatives, like 3-methyl-7-chlorobenzo-4H-1,2,4-thiadiazine 1,1-dioxide, diazoxide and 7-chloro-3-isopropylamino-4H-benzo-1,2,4-thiadiazine 1,1-dioxide, BPDZ 73, are potent openers of Kir6.2/SUR1 K-ATP channels. To explore the structure-activity relationship of this series of K-ATP openers, 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyano-methylsulfonylphenyl)acylamide derivatives were synthesized from 2-acetylamino-5-chloro-benzenesulfonic acid pyridinium salt or 2-aminobenzenethiols. The 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide derivatives (e.g., 7-chloro-3-isopropylamino-4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide, 3f) were found to activate K-ATP channels as indicated by their ability to hyperpolarize beta cell membrane potential, to inhibit glucose-stimulated insulin release in vitro and to increase ion currents through Kir6.2/SUR1 channel as measured by patch clamp. The potency and efficacy of, for example, 3f is however significantly reduced compared to the corresponding 4H-1,2,4-benzothiadiazine 1,1-dioxide derivatives. Opening of the 4H-1,2,4-thiadiazine ring to get (e.g., 2-cyanomethylsulfonyl-4-fluorophenyl) carbamic acid isopropyl ester (4c) gives rise to compounds, which are able to open K-ATP channels but with considerable reduced potency compared to, for example, diazoxide. Compound 3a, 7-chloro-3-methyl-4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide, which inhibits insulin release in vitro from beta cells and rat islets, reduces plasma insulin levels and blood pressure in anaesthetized rats upon intravenous administration. (C) 2004 Elsevier Ltd. All rights reserved.